Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
7
×
new york top stories
startups
7
×
deals
national top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
cancer
detroit blog main
detroit top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
eli lilly
indiana blog main
indiana top stories
national
abbvie
alzheimer's disease
cancer immunotherapy
fda
investing
johnson & johnson
merck
pfizer
What
companies
7
×
bio
roundup
drug
life
led
nash
news
price
science
startup
street
wall
week
admits
ago
alzheimer’s
appear
approval
approved
big
biggest
biogen’s
biopharmaceutical
biotech
biotechs
black
boost
classes
combinator
continue
convo
deal
debut
deerfield
diamond
diamond’s
didn't
different
digital
Language
unset
Current search:
companies
×
startups
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
